216 related articles for article (PubMed ID: 19837943)
1. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.
Zhou C; Wawrowsky K; Bannykh S; Gutman S; Melmed S
Mol Endocrinol; 2009 Dec; 23(12):2000-12. PubMed ID: 19837943
[TBL] [Abstract][Full Text] [Related]
2. Oct-1 induces pituitary tumor transforming gene expression in endocrine tumors.
Zhou C; Tong Y; Wawrowsky K; Bannykh S; Donangelo I; Melmed S
Endocr Relat Cancer; 2008 Sep; 15(3):817-31. PubMed ID: 18550719
[TBL] [Abstract][Full Text] [Related]
3. PTTG1 attenuates drug-induced cellular senescence.
Tong Y; Zhao W; Zhou C; Wawrowsky K; Melmed S
PLoS One; 2011; 6(8):e23754. PubMed ID: 21858218
[TBL] [Abstract][Full Text] [Related]
4. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
5. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.
Horwitz GA; Miklovsky I; Heaney AP; Ren SG; Melmed S
Mol Endocrinol; 2003 Apr; 17(4):600-9. PubMed ID: 12554778
[TBL] [Abstract][Full Text] [Related]
6. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene.
Lee UE; Ghiassi-Nejad Z; Paris AJ; Yea S; Narla G; Walsh M; Friedman SL
FEBS Lett; 2010 Mar; 584(5):1006-10. PubMed ID: 20116377
[TBL] [Abstract][Full Text] [Related]
8. Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition.
Tong Y; Tan Y; Zhou C; Melmed S
Oncogene; 2007 Aug; 26(38):5596-605. PubMed ID: 17353909
[TBL] [Abstract][Full Text] [Related]
9. The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.
Massimi I; Guerrieri F; Petroni M; Veschi V; Truffa S; Screpanti I; Frati L; Levrero M; Gulino A; Giannini G
Mol Carcinog; 2013 Jul; 52(7):526-34. PubMed ID: 22389255
[TBL] [Abstract][Full Text] [Related]
10. Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
Liang M; Chen X; Liu W; Li S; Li C; Jiang L; Lv S
Cancer Biol Ther; 2011 Feb; 11(3):337-45. PubMed ID: 21099350
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.
Vlotides G; Cruz-Soto M; Rubinek T; Eigler T; Auernhammer CJ; Melmed S
Mol Endocrinol; 2006 Dec; 20(12):3321-35. PubMed ID: 16959877
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation.
Pillai S; Kovacs M; Chellappan S
Cancer Res; 2010 Jun; 70(12):4931-40. PubMed ID: 20516113
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A
Cancer Cell; 2006 Jun; 9(6):459-71. PubMed ID: 16766265
[TBL] [Abstract][Full Text] [Related]
15. PTTG overexpression is correlated with angiogenesis in human pituitary adenomas.
Minematsu T; Suzuki M; Sanno N; Takekoshi S; Teramoto A; Osamura RY
Endocr Pathol; 2006; 17(2):143-53. PubMed ID: 17159247
[TBL] [Abstract][Full Text] [Related]
16. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
17. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
18. ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.
Zhi T; Jiang K; Xu X; Yu T; Zhou F; Wang Y; Liu N; Zhang J
Neuro Oncol; 2019 Mar; 21(4):462-473. PubMed ID: 30590814
[TBL] [Abstract][Full Text] [Related]
19. Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis.
Chesnokova V; Kovacs K; Castro AV; Zonis S; Melmed S
Mol Endocrinol; 2005 Sep; 19(9):2371-9. PubMed ID: 15919720
[TBL] [Abstract][Full Text] [Related]
20. Securin overexpression correlates with the activated Rb/E2F1 pathway and histone H3 epigenetic modifications in raw areca nut-induced carcinogenesis in mice.
Boruah N; Singh CS; Swargiary P; Dkhar H; Chatterjee A
Cancer Cell Int; 2022 Jan; 22(1):30. PubMed ID: 35033090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
